IMTX · Immatics N.V
United States · RS rating 10 · As of 2026-10-14
| Price | 7.00 USD |
|---|---|
| 1-day change | +2.5% |
| RS rating (overall / 1M / 3M / 12M) | 10 / 13 / 14 / 21 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 26 / 15 / 5 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -7.0% |
| Sales growth Q/Q | +281.0% |
| Distance from 52-week high | +41.0% |
| Market cap (USD) | $1.5B |